Document is current
Any future updates will be listed below
-
Authors
Li, Haining
Chen, Yu
Yang, Yuanyuan
Meng, Yunlong
Liu, Kangyu
Tang, Xingkun
Zhong, Zilin
Chen, Jianjun
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2021YFA1101300)
Double Thousand Plan of Jiangxi Province (jxsq2023102228)
Open Research Fund of Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases (gect-2025-Z03)
- License Information
-
More Information
Article History
Received: 19 March 2026
Accepted: 13 August 2026
First Online: 18 August 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Institutional Review Board (IRB) of Tongji University School of Medicine (Shanghai, China; Approval No. 2021tjdx061) and conducted in accordance with the Declaration of Helsinki. Informed written consent was obtained from all participants or their legal guardians prior to enrollment.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
